MRI Contrast Media
We launched the first contrast medium for magnetic resonance imaging in 1988, setting a further milestone in the development of contrast media.
The special characteristics of the first MRI contrast medium were improved contrast and extended application possibilities. By 2006, it had been successfully used over 70 million times and helped to make Bayer HealthCare Pharmaceuticals the world market leader in MRI contrast media.
New insights with new technologies
More recent developments in MRI contrast media include a substance for examinations that require a high concentration of contrast media – such as an MRI of the brain or for visualizing the blood flows in tumors. They also include an organ-specific contrast medium which allows an exact diagnosis of even small lesions of the liver. This contrast medium is absorbed specifically by liver cells and therefore enhances contrast in healthy liver tissue. Any pathological changes of the organ caused by tumors, metastases or other malignant or benign lesions that exhibit little or no liver-cell function can be detected, located and characterized in this way.